UP Drug Raid in Kanpur: ₹7.5 Crore Worth of Narcotics Seized; Two Officials Removed for Lapses

Kanpur–  In a major operation against the illegal trade of intoxicant medicines, a team led by Food Safety and Drug Administration Commissioner Dr. Roshan Jacob raided multiple pharmaceutical firms in Kanpur on Tuesday, seizing codeine-based cough syrups, Tramadol tablets, and expired drugs valued at approximately ₹7.5 crore. The raids, targeting warehouses in areas like Birhana Road and Koparganj, exposed significant irregularities in storage and distribution, leading to the sealing of several premises and directives for legal action.

The targeted firms included Agarwal Brothers (owned by Vinod Agarwal), Medisina Healthcare and Vedansh Pharmaceutical (linked to Shivam Agarwal and Anmol Gupta), and Mosaico Agencies (owned by Abhishek Sharma and Manju Sharma). Inspectors discovered large quantities of controlled substances without proper documentation, along with attempts to tamper with evidence, such as the removal of computers and records. The syrups were reportedly sourced from a Himachal Pradesh-based laboratory, and the owners failed to provide accounting details during the inspection.

Dr. Jacob, who spearheaded the coordinated effort involving officials from various districts, highlighted the raid’s focus on curbing the misuse of pharmaceuticals as narcotics. “These operations are crucial to breaking the chains of addiction that exploit vulnerable populations,” he said. Samples from the seized items have been dispatched for lab testing, and all raided warehouses remain sealed pending further inventory.

In a significant development following the raid, Assistant Commissioner (Medicine) Dinesh Kumar Tiwari and Drug Inspector Rekha Sachan have been removed from their positions for failing to control the illegal sale of codeine-based cough syrups and other narcotics. The officials have been instructed to report to headquarters by November 17. This action underscores accountability measures amid revelations of ongoing irregularities in the region’s drug trade.

First Information Reports (FIRs) are being filed against the implicated firms under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and the Bharatiya Nyaya Sanhita (BNS). Additionally, previous FIRs against other entities, including AS Healthcare, Balaji Medicals, Maa Durga Medicoz, and RS Healthcare, will be amended to include NDPS sections due to similar violations.

A prior inspection on June 28 had already flagged issues, with samples collected and sales restrictions imposed on certain drugs. Authorities suspect these networks contribute to broader interstate and cross-border smuggling, fueling substance abuse among the youth.

Community leaders and health advocates have praised the crackdown, urging continued enforcement to foster a safer, drug-free environment in Uttar Pradesh. Investigations are ongoing to uncover potential links to larger syndicates.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert